Skip to main content

Table 4 Worldwide general estimating equations model 1 for ″treatment limitation vs. failed cardiopulmonary resuscitation.”

From: Derivation and performance of an end-of-life practice score aimed at interpreting worldwide treatment-limiting decisions in the critically ill

 

Estimate

OR

95% CI

P value

Lower

Upper

Region

     

 America Latin vs. Africa

1.90

6.66

0.81

54.94

0.08

 America Northern vs. Africa

2.58

13.20

1.47

118.28

0.02

 Asia vs. Africa

2.57

13.10

1.73

98.89

0.013

 Australia/New Zealand vs. Africa

3.31

27.35

3.32

225.03

0.002

 Europe Central vs. Africa

2.20

9.02

1.20

67.81

0.03

 Europe Northern vs. Africa

3.80

44.83

5.89

341.23

 < 0.001

 Europe Southern vs. Africa

2.05

7.79

1.05

58.08

0.045

Age

0.01

1.01

1.01

1.02

 < 0.001

Sex, female vs. male

0.05

1.05

0.95

1.16

0.37

Acute diagnoses

     

 Surgery vs. neurologic

− 0.53

0.59

0.48

0.72

 < 0.001

 Respiratory vs. neurologic

− 0.54

0.58

0.49

0.70

 < 0.001

 Cardiovascular vs. neurologic

− 1.01

0.36

0.29

0.45

 < 0.001

 Gastrointestinal vs. neurologic

− 0.45

0.64

0.50

0.81

 < 0.001

 Metabolic vs. neurologic

− 0.52

0.60

0.43

0.83

0.002

 Hematologic vs. neurologic

− 0.70

0.50

0.36

0.69

 < 0.001

 Trauma vs. neurologic

− 1.11

0.33

0.22

0.49

 < 0.001

 Sepsis vs. neurologic

− 0.61

0.54

0.45

0.67

 < 0.001

 Other vs. neurologic

− 0.99

0.37

0.25

0.55

 < 0.001

Chronic diseases

     

 Cardiovascular diseases vs. none

0.13

1.14

0.95

1.36

0.17

 Neurological-cognitive diseases–muscular vs. none

0.57

1.77

1.38

2.28

 < 0.001

 Chest vs. none

0.38

1.46

1.16

1.84

0.001

 Kidney vs. none

0.14

1.15

0.88

1.50

0.31

 Digestive system vs. none

0.47

1.60

1.22

2.09

0.001

 Immunologic system vs. none

0.33

1.39

0.95

2.05

0.09

 General history vs. none

0.24

1.28

1.02

1.60

0.04

 Cancer vs. none

0.53

1.70

1.33

2.17

 < 0.001

 Unknown vs. none

− 0.26

0.77

0.56

1.07

0.12

Center type (private vs. public)

− 0.57

0.57

0.33

0.98

0.04

Weighted and rescaled end-of-life practice score

0.12

1.12

1.03

1.22

0.008

Intercept

− 1.94

0.14

0.02

1.11

0.06

  1. Patient data originate from the entire worldwide study population (n = 11,574) [5]. The comparison-study [4] derived, weighted and rescaled end-of-life practice score is included as explanatory variable (see also Methods)
  2. CI, confidence interval; OR, odds ratio. Collinearity assessment: variance inflation, 1.01–1.18; condition index, 18.32. The results on the variable of interest, i.e. the end-of-life practice score, are highlighted in bold
Back to article page

Critical Care

ISSN: 1364-8535